← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Synbal, Inc.
Carlsbad, CA
$4,100,259
Total funding
2
Grants
Funding over time
peak $2M · FY2018–23$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,100,259 · 2
By mechanism
N01$2,300,000 · 1
R44$1,800,259 · 1
Investigators at Synbal, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
IGF::OT::IGF Topic 372 Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics- Moonshot$2,000,000
N44 · FY2019 · CA
Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.$1,000,000
R44 · FY2022 · AI
Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.$566,896
R44 · FY2023 · AI
IGF::OT::IGF Topic 372 Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics- Moonshot$300,000
N01 · FY2018 · CA
Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.$233,363
R44 · FY2021 · AI